In particular, patients with Fabry's disease often have pale gray, yellow, or brown streaks on the cornea of their eye. These streaks are known as corneal opacities or corneal verticillata.

Expert Rev Ophthalmol. 2008;3(2):177-192. Clinically, cornea verticillata associated with amiodarone, (hydroxy-)chloroquine and Fabry's disease may be difficult to discriminate. As Fabry's disease ...

Amicus Therapeutics’ first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy.

This metabolic defect leads to numerous symptoms, including eye problems due to accumulation of cholesterol on the cornea ... for the treatment of Fabry disease, a rare genetic lysosomal-storage ...

Experts And Viewpoints, August 23, 2021 Metagenomics May Enhance the Diagnosis of Infectious Keratitis Dr Christopher Rapuano evaluates a new study comparing standard corneal cultures with ...

Sangamo Therapeutics has identified a shortcut to market for its Fabry disease candidate, aligning with the FDA on a pathway that could slash three years from the time to market and free it from ...

Italian pharma Chiesi has begun a new rare diseases division as it builds towards a potential commercial launch for its Fabry Disease therapy. Chiesi, which is best known for its respiratory drugs ...

Narrator With the help of an innovative procedure known as dsaek, Jolie will have the damaged portion of his cornea replaced by eye surgeon Rick Fraunfelder of Portland's Casey Eye Institute.

The graduate engineer has Fabry disease, which damages the heart, kidneys and nervous system, and cannot access treatment in his home country. The Home Office says it still intends to remove him ...

Jeff Fabry is well-known in international archery as a five-time world championships medalist, three-time Paralympic Games medalist, and a member of Team USA for London in 2012. Fabry was injured ...

for the treatment of motor neurone disease TA20 23 January 2001 23 January 2001 Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma TA10 23 August ...